Senores Pharmaceuticals Ltd (SENORES) — Board Meeting | 25 September 2026

25 September 2026 · BSE 🟡 Notable Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

9th AGM held on September 25, 2026 via video conference.

🔄 What Changed

Reappointment of directors Sanjay Majmudar and Arpit Shah; appointment of Viranchi Shah as independent director; approval of 2026 Employee Stock Option Scheme.

🔮 What's Next

None

💡 Investor Takeaway

Shareholders approved key governance and compensation measures, signaling confidence in leadership continuity and employee incentive plans.

Senores Pharmaceuticals held its 9th AGM on September 25, 2026 via video conference, adopting audited financials for FY2026, reappointing directors Sanjay Majmudar and Arpit Shah, appointing Viranchi Shah as independent director, and approving the 2026 Employee Stock Option Scheme and its grant to subsidiary employees.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SENORES ✨ Ask AI About This

About Senores Pharmaceuticals Ltd (SENORES)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹6,226.21 CrP/E: 47.6ROE: 13.5%ROCE: 15.6%

View full SENORES stock details →

📡 Get AI alerts when SENORES files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SENORES — Free

💡 Ask AI about this filing

"What is the expected dilution impact from the 2026 Employee Stock Option Scheme?""How does the new independent director affect board composition?""What is the projected EPS impact of the approved financial statements?"

Ask AI Free →

📊 More SENORES filings

Announcement — 24 September 2026Senores Pharmaceuticals announced that its trading window will close on October 1, 2026, and remain ...
Announcement — 21 September 2026Senores Pharmaceuticals clarified that recent trading volume changes are normal market fluctuations ...
🔴 Announcement — 11 September 2026Senores Pharmaceuticals announced that its subsidiary Apnar Pharma completed a USFDA inspection at i...
🔴 Annual Report — 9 September 2026Senores Pharmaceuticals reported FY 2025-26 revenue of **[amount context mismatch] crores**, up from...
🔴 Annual Report — 3 September 2026Senores Pharmaceuticals Ltd (SENORES) held its 9th AGM on September 25, 2026, approving key governan...

See all SENORES filings →

🔥 Also filed on 25 September 2026

JSWCEMENTJSW Cement LtdOffer Document HARSHAHarsha Engineers International LtdAnnouncement VASCONEQVascon Engineers LtdAnnouncement JSWSTEELJSW Steel LtdOffer Document 512441Enbee Trade & Finance LtdInsider Trading 531997IKOMA Technologies LimitedCorporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SENORES files new disclosures

Track SENORES filings, board meetings, and corporate actions. Free email alerts at 5 PM.